Food intolerance and diagnostics company Omega Diagnostics has gained an order for VISITECT CD4 advanced disease from Zimbabwe.
Unlike the previous Nigerian order, this is not dependent on any approvals. The order is worth £80,000 (for 20,000 units) and it is not being sold to NGOs. The advanced disease test got its CE mark in March 2019 and it is being reviewed by UNITAID and then, if approved, it can be sold to NGOs.
The share price has perked up since the announcement and is 10.25p.
© 2020 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Background check services provider ClearStar Inc has won a contract with a facilities management business.
WH Ireland is downgrading its estimates for recruitment software provider Dillistone.
Starcom says that 2019 performance was in line with expectations.